Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04904-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Indumathi Thangavelu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, CHRIST (Deemed to Be University), Bangalore, 560029, India. Hauptthemen laut MEDLINE: Chitosan, Nanocomposites, Antineoplastic Agents, Ferric Compounds. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Nanoparticles for biomedical applications often suffer from limited stability, low biocompatibility, and suboptimal therapeutic efficacy. To address these challenges, NiFe₂O₄ nanoparticles were functionalized with chitosan (NiFe₂O₄-CS) via a co-precipitation method, aiming to enhance their structural, optical, antimicrobial, and anticancer properties. XRD analysis revealed a reduction in crystallite size from 37 to 33 nm after chitosan modification, indicating controlled crystal growth and increased surface area. TEM results confirmed a corresponding decrease in particle size from 35 ± 2.1 nm to 29 ± 1.8 nm, improving surface reactivity and stability. PL spectra exhibited a red-shift in green emission peaks, suggesting increased oxygen vacancies and defect states that facilitate ROS generation. Antimicrobial assays against methicillin-resistant Staphylococcus aureus (MRSA) and Candida albicans (C.albicans) demonstrated significantly higher activity for NiFe₂O₄-CS nanocomposites, supported by SEM imaging that showed extensive microbial membrane disruption. Furthermore, NiFe₂O₄-CS exhibited enhanced anticancer activity against C6 glioma cells, with an IC₅₀ of 35.6 µg/mL compared to 43.6 µg/mL for unmodified nanoparticles. Zebrafish embryo studies confirmed the biocompatibility of NiFe₂O₄-CS at appropriate doses, although dose-dependent embryotoxicity was observed. These findings highlight that chitosan functionalization of dual-metal nanoparticles improves therapeutic efficacy through increased surface interactions and ROS generation while underscoring the need for careful dose optimization. This study presents a novel strategy for designing biopolymer-coated nanocomposites that balance enhanced biomedical performance with safety considerations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, CHRIST (Deemed to Be University), Bangalore, 560029, India.
- Department of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11432, Riyadh, Kingdom of Saudi Arabia. stadepalli@imamu.edu.sa.
Zitieren
APA
Thangavelu, I., & Tadepalli, S. (2026). Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04904-3
Vancouver
Thangavelu I, Tadepalli S. Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04904-3
BibTeX
@article{Thangavelu2026,
author = {Thangavelu, Indumathi and Tadepalli, Srinivas},
title = {Chitosan coated multifunctional NiFe₂O₄ nanocomposites as a promising candidate for biomedical applications},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04904-3}
}
EUVIMED